Long-Term Outcomes With Isatuximab-Carfilzomib-Dexamethasone (Isa-Kd) in Relapsed Multiple Myeloma (MM) Patients (pts) With 1q21+Status: Updated Results from the Phase 3 IKEMA Study

被引：0

作者：

Facon, Thierry ^{[1
]}

Moreau, Philippe ^{[2
]}

Spicka, Ivan ^{[3
]}

Suzuki, Kenshi ^{[4
]}

Yong, Kwee ^{[5
]}

Mikhael, Joseph ^{[6
]}

Fukao, Taro ^{[7
]}

Bisht, Kamlesh ^{[7
]}

Armstrong, Nicole ^{[8
]}

Mace, Sandrine ^{[9
]}

Risse, Marie-Laure ^{[10
]}

Martin, Thomas ^{[11
]}

机构：

[1] Lille Univ Hosp, Dept Hematol, Lille, France

[2] Univ Hosp Hotel Dieu, Dept Hematol, Nantes, France

[3] Charles Univ & Gen Hosp, Fac Med 1, Dept Hematol, Prague, Czech Republic

[4] Japanese Red Cross Med Ctr, Myeloma Amyloidosis Ctr, Tokyo, Japan

[5] Univ Coll Hosp, Dept Haematol, London, England

[6] City Hope Canc Ctr, Translat Genom Res Inst, Phoenix, AZ USA

[7] Sanofi, Global Oncol, Cambridge, MA USA

[8] Sanofi, Global Med Affairs, Cambridge, MA USA

[9] Sanofi, Res & Dev, Chilly Mazarin, France

[10] Sanofi, Res & Dev, Vitry Sur Seine, France

[11] Univ Calif San Francisco, Med Ctr, San Francisco, CA USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

1q21; IKEMA; isatuximab; carfilzomib; dexamethasone; multiple myeloma; phase III;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MM-248

引用

页码：S484 / S485

页数：2

共 50 条

[41] Long-Term Ixazomib Maintenance Is Tolerable and Improves Depth of Response Following Ixazomib-Lenalidomide-Dexamethasone Induction in Patients (Pts) with Previously Untreated Multiple Myeloma (MM): Phase 2 Study Results
Kumar, Shaji
Berdeja, Jesus G.
Niesvizky, Ruben
Lonial, Sagar
Laubach, Jacob P.
Hamadani, Mehdi
Stewart, Keith
Hari, Parameswaran N.
Roy, Vivek
Vescio, Robert
Kaufman, Jonathan L.
Berg, Deborah
Liao, Eileen
Hui, Ai-Min
Rajkumar, S. Vincent
Richardson, Paul G.
BLOOD, 2014, 124 (21)
[42] EFFICACY AND SAFETY OF CARFILZOMIB AND DEXAMETHASONE VS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA BASED ON CYTOGENETIC RISK STATUS: SUBGROUP ANALYSIS FROM THE PHASE 3 STUDY ENDEAVOR (NCT01568866)
Maria Victoria, Mateos Manteca
Stefan, Knop
Paul, Fermand Jean
Roman, Hajek
Heinz, Ludwig
Shibao, Feng
Nehal, Mohamed
Heidi, Gillenwater H.
Karim, Iskander
Hartmut, Goldschmidt
HAEMATOLOGICA, 2016, 101 : 26 - 27
[43] OPROZOMIB (OPZ) AND DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED RESULTS FROM DOSE ESCALATION IN A PHASE 1B/2, MULTICENTER, OPEN-LABEL STUDY
Hari, P.
Shain, K. H.
Voorhees, P.
Gabrail, N.
Abidi, M.
Zonder, J.
Boccia, R.
Richardson, P. G.
Neuman, L.
Wong, H.
Dixon, S.
Prada, C. P.
HAEMATOLOGICA, 2015, 100 : 254 - 255
[44] Efficacy and Safety of Carfilzomib and Dexamethasone (Kd) Vs Bortezomib and Dexamethasone (Vd) in Patients With Relapsed Multiple Myeloma By Prior Autologous Stem Cells Transplantation: Secondary Analysis From the Phase 3 Endeavor Study (NCT01568866)
Mateos, M. -V.
Knop, S.
Fermand, J. -P.
Hajek, R.
Ludwig, H.
Feng, S.
Mohamed, N.
Gillenwater, H. H.
Iskander, K.
Goldschmidt, H.
BONE MARROW TRANSPLANTATION, 2016, 51 : S17 - S18
[45] Phase (Ph) I/II study of elotuzumab (Elo) plus lenalidomide/dexamethasone (Len/dex) in relapsed/refractory multiple myeloma (RR MM): Updated Ph II results and Ph I/II long-term safety
Lonial, Sagar
Jagannath, Sundar
Moreau, Philippe
Jakubowiak, Andrzej J.
Raab, Marc S.
Facon, Thierry
Vij, Ravi
Bleickardt, Eric
Reece, Donna Ellen
Benboubker, Lotfi
Zonder, Jeffrey A.
Deng, Wei
Singhal, Anil K.
Richardson, Paul Gerard Guy
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[46] Subcutaneous (SC) Isatuximab (Isa) Administration by an On-Body Delivery System (OBDS) in Combination With Pomalidomide-Dexamethasone (Pd) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients: Interim Phase 1b Study Results
Quach, Hang
Parmar, Gurdeep
Ocio, Enrique M.
Prince, H. Miles
Oriol, Albert
Tsukada, Nobuhiro
Sunami, Kazutaka
Bories, Pierre
Karanes, Chatchada
Madan, Sumit
Semiond, Dorothee
Inchauspe, Marlene
Mace, Sandrine
Suzan, Florence
Moreau, Philippe
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S404 - S405
[47] Efficacy and Safety of Carfilzomib, Lenalidomide, and Dexamethasone Vs Lenalidomide and Dexamethasone in Patients with Relapsed Multiple Myeloma Based on Cytogenetic Risk Status: Subgroup Analysis from the Phase 3 Study Aspire (NCT01080391)
Avet-Loiseau, Herve
Fonseca, Rafael
Siegel, David
Dimopoulos, Meletios A.
Spicka, Ivan
Masszi, Tamas
Hajek, Roman
Rosinol, Laura
Goranova-Marinova, Vesselina
Mihaylov, Georgi
Maisnar, Vladimir
Mateos, Maria -Victoria
Wang, Michael
Niesvizky, Ruben
Oriol, Albert
Jakubowiak, Andrzej
Minarik, Jiri
Palumbo, Antonio
Bensinger, William
Kukreti, Vishal
Ben-Yehuda, Dina
Tonda, Margaret
Obreja, Mihaela
Moreau, Philippe
BLOOD, 2015, 126 (23)
[48] Long-Term Outcomes from the Phase 3 OCEAN (OP-103) Study: Melflufen and Dexamethasone (Dex) Versus Pomalidomide (Pom) and Dex in Relapsed Refractory Multiple Myeloma (RRMM)
Schjesvold, Fredrik
Dimopoulos, Meletios A.
Delimpasi, Sosana
Robak, Pawel
Coriu, Daniel
Legiec, Wojciech Maciej
Pour, Ludek
Spicka, Ivan
Masszi, Tamas
Doronin, Vadim Anatolievich
Minarik, Jiri
Salogub, Galina
Alexeeva, Yulia
Lazzaro, Antonio
Maisnar, Vladimir
Mikala, Gabor
Norin, Stefan
Thuresson, Marcus
Bergan, Anna
Obermuller, Jakob
Hajek, Roman
Mateos, Maria-Victoria
Richardson, Paul G.
Sonneveld, Pieter
BLOOD, 2023, 142
[49] Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
Dimopoulos, M. A.
Chen, C.
Spencer, A.
Niesvizky, R.
Attal, M.
Stadtmauer, E. A.
Petrucci, M. T.
Yu, Z.
Olesnyckyj, M.
Zeldis, J. B.
Knight, R. D.
Weber, D. M.
LEUKEMIA, 2009, 23 (11) : 2147 - 2152
[50] Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
M A Dimopoulos
C Chen
A Spencer
R Niesvizky
M Attal
E A Stadtmauer
M T Petrucci
Z Yu
M Olesnyckyj
J B Zeldis
R D Knight
D M Weber
Leukemia, 2009, 23 : 2147 - 2152

← 1 2 3 4 5 →